Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]
PHH, HepG2 or HepaRG for Drug Induced Liver Injury Studies?
Drug-induced liver injury (DILI) is one of the most frequent causes of safety-related drug marketing withdrawal, according to the [...]
Happy Holidays from Visikol
As we approach the end of 2020, we want to express our gratitude to our partners and customers. We [...]
Happy Thanksgiving from Visikol
While this year we may not be gathering around the table with family and friends, we want to wish [...]
Visikol Adds the Leica Aperio VERSA 8 Fluorescent Slide Scanner
Visikol added the Leica Biosystems’ Aperio VERSA 8 slide scanner to its services as the company expands its suite [...]
Visikol Launches Multiplex Slide Imaging and Analysis Services
The Visikol research team has developed a novel tissue multiplexing approach which leverages a proprietary antibody [...]
Visikol CEO and Co-founder to Participate in Startup Webinar
Join us on Wednesday, December 2nd for an online webinar hosted by the Foundation for Health [...]
Visikol, Corning and Molecular Devices NASH 3D Cell Culture Webinar
Did you miss our NASH 3D cell culture webinar with Corning and Molecular Devices on October 14th? If [...]
Visikol Leverages Precisionary Compresstome to Offer PCLS Assays
Visikol, a leading provider of advanced cell culture assay services, has recently expanded its portfolio of in vitro assays [...]